Holen Sie sich die Stockscreener-App
2.06
0.48%
-0.010
Vorhandelsmarkt:
2.05
-0.01
-0.49%
Schlusskurs vom Vortag:
$2.07
Offen:
$2.09
24-Stunden-Volumen:
119.73K
Relative Volume:
0.32
Marktkapitalisierung:
$194.78M
Einnahmen:
$72.76M
Nettoeinkommen (Verlust:
$35.34M
KGV:
5.5781
EPS:
0.3693
Netto-Cashflow:
$-62.91M
1W Leistung:
-5.07%
1M Leistung:
+17.05%
6M Leistung:
+49.28%
1J Leistung:
+31.21%
1-Tages-Spanne:
$2.06
$2.165
1-Wochen-Bereich:
$2.05
$2.165
52-Wochen-Spanne:
$1.13
$2.38
Compugen Ltd Stock (CGEN) Company Profile
Compare CGEN vs VRTX, REGN, ALNY, ARGX, INSM
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CGEN
Compugen Ltd
|
2.06 | 194.78M | 72.76M | 35.34M | -62.91M | 0.3693 |
VRTX
Vertex Pharmaceuticals Inc
|
454.97 | 115.58B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
749.47 | 79.23B | 14.34B | 4.50B | 3.77B | 41.56 |
ALNY
Alnylam Pharmaceuticals Inc
|
328.70 | 43.59B | 3.71B | 313.75M | 465.38M | 2.2571 |
ARGX
Argen X Se Adr
|
697.05 | 43.26B | 4.16B | 1.29B | 734.26M | 19.58 |
INSM
Insmed Inc
|
148.31 | 31.97B | 606.42M | -1.28B | -997.58M | -6.403 |
Compugen Ltd Stock (CGEN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-07 | Eingeleitet | H.C. Wainwright | Buy |
| 2025-01-13 | Eingeleitet | Oppenheimer | Outperform |
| 2022-08-05 | Herabstufung | Jefferies | Buy → Hold |
| 2020-05-26 | Fortgesetzt | JMP Securities | Mkt Outperform |
| 2020-05-13 | Eingeleitet | Stifel | Buy |
| 2020-05-07 | Eingeleitet | SVB Leerink | Outperform |
| 2020-04-22 | Eingeleitet | ROTH Capital | Buy |
| 2020-03-24 | Eingeleitet | SunTrust | Buy |
| 2020-01-16 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2018-03-29 | Eingeleitet | Oppenheimer | Outperform |
| 2016-02-01 | Fortgesetzt | Oppenheimer | Outperform |
| 2015-10-15 | Eingeleitet | FBR Capital | Outperform |
| 2015-04-23 | Fortgesetzt | Jefferies | Buy |
| 2015-04-21 | Eingeleitet | Oppenheimer | Outperform |
| 2014-02-07 | Eingeleitet | MLV & Co | Buy |
| 2009-12-28 | Bestätigt | Cantor Fitzgerald | Buy |
| 2009-07-29 | Eingeleitet | Cantor Fitzgerald | Buy |
Alle ansehen
Compugen Ltd Aktie (CGEN) Neueste Nachrichten
RSI Check: Does Compugen Ltd meet Warren Buffetts criteria2026 Gainers & Verified Swing Trading Watchlist - baoquankhu1.vn
If You Invested $1,000 in Compugen (CGEN) - Stock Titan
Aug Highlights: Is Compugen Ltd stock forming a triangle pattern2026 Performance Recap & Real-Time Volume Surge Alerts - baoquankhu1.vn
Retail Trends: Will Compugen Ltd outperform the market in YEARWeekly Gains Summary & Real-Time Volume Surge Alerts - baoquankhu1.vn
Compugen Ltd. (NASDAQ:CGEN) Q4 2025 earnings call transcript - MSN
Compugen shares jump nearly 5% after strong Q4 earnings beat - MSN
Compugen (CGEN) director discloses initial share and option holdings - Stock Titan
CGEN (COMPUGEN LTD) CFO David Silberman discloses initial share and option holdings - Stock Titan
Compugen (CGEN) director discloses initial shares, RSUs and option grants - Stock Titan
Compugen (CGEN) director Eran Perry details shares, RSUs and options - Stock Titan
Compugen (CGEN) CEO Ophir Eran details share and long-dated option holdings - Stock Titan
Compugen (CGEN) CMO Michelle Mahler details option and RSU holdings - Stock Titan
[Form 3] COMPUGEN LTD Initial Statement of Beneficial Ownership - Stock Titan
Compugen (CGEN) director Mathias Hukkelhoven details initial equity holdings - Stock Titan
Compugen (CGEN) director Holcomb reports shares, options and RSUs - Stock Titan
Halevy Gilead discloses initial Compugen (CGEN) share and option holdings - Stock Titan
Compugen (CGEN) COO discloses 400,000 share options in Form 3 - Stock Titan
Compugen (CGEN) director Anat Cohen-Dayag reports initial share and option holdings - Stock Titan
Compugen (CGEN) SVP reports RSU and option stakes in Form 3 filing - Stock Titan
Sectors Review: What is the cash position of Compugen Ltd2026 Price Momentum & Safe Capital Preservation Plans - baoquankhu1.vn
Movement Recap: Whats the analyst consensus on Compugen LtdWeekly Risk Report & AI Forecasted Stock Moves - baoquankhu1.vn
Compugen Ltd. (CGEN) reports Q4 revenue of $67.3 million vs. $1.5 million last year - MSN
Institution Moves: How is Compugen Ltd managing supply chain issuesQuarterly Earnings Summary & Weekly Chart Analysis and Guides - baoquankhu1.vn
Compugen Ltd. (CGEN) Reports Q4 Revenue of $67.3 Million vs. $1.5 Million Last Year - Insider Monkey
Compugen (CGEN) Q4 2025 Earnings Call Transcript - AOL.com
Compugen at Leerink Global Healthcare Conference: Strategic Insights By Investing.com - Investing.com Australia
Compugen at Leerink Global Healthcare Conference: Strategic Insights - Investing.com South Africa
Short Squeeze: Is Compugen Ltd stock forming a triangle pattern2026 PreEarnings & Consistent Growth Stock Picks - baoquankhu1.vn
CGEN Earnings History & Surprises | EPS & Revenue Results | COMPUGEN LTD (NASDAQ:CGEN) - ChartMill
Q1 Earnings Estimate for Compugen Issued By HC Wainwright - Defense World
BillionToOne Stock at $89: Why a New $19.1 Million Position Could Matter Now - AOL.com
3 Reasons Exelixis Stock Could Deliver Market‑Beating Returns Over the Next Decade - AOL.com
Compugen Q4 Earnings Call Highlights - Defense World
Compugen Ltd (CGEN) Q4 2025 Earnings Call Highlights: Strong Rev - GuruFocus
Why Tempus AI Stock Is Up Today — And What to Watch Before Next Week’s Earnings - AOL.com
Cumberland (CPIX) Q4 2025 Earnings Call Transcript - AOL.com
Compugen Ltd. (NASDAQ:CGEN) Q4 2025 Earnings Call Transcript - Insider Monkey
Compugen Ltd (CGEN) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ... By GuruFocus - Investing.com Canada
Compugen (CGEN) Quarterly Loss Near US$7 Million Tests Bullish Profitability Narrative - simplywall.st
From Sizable Stake to Zero: The Likely Reason Why Agios Shares Lost a $94 Million Backer - AOL.com
Investment Advisor Bets Big on CMPX Stock, Adds 2.5 Million Shares, According to Latest SEC Filing - AOL.com
Compugen earnings beat by $0.68, revenue topped estimates - Investing.com South Africa
Chegg Earnings: Big Quarter Sends Shares Higher - AOL.com
Compugen: Non-Dilutive Funding For Rilvegostomig Obtained And GS-0321 Advancement (CGEN) - Seeking Alpha
Compugen Ltd. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025 - marketscreener.com
Compugen Q4 2025 Earnings Call Transcript - MarketBeat
Compugen Ltd. Q4 2025 Earnings Call Summary - Yahoo Finance
12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga
What Smart Money Loves About Lilly - AOL.com
Viridian Therapeutics Stock Up 75%, but One Fund Just Sold Off Its $69 Million Stake - AOL.com
Earnings call transcript: Compugen Q4 2025 sees earnings beat, stock surges - Investing.com
Finanzdaten der Compugen Ltd-Aktie (CGEN)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.82%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):